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Summary
The first hematopoietic stem cells (HSCs) that engraft irradiated adult mice arise in the
aortagonad-mesonephros (AGM) on embryonic day 11.5 (E11.5). However, at this stage there is a
discrepancy between the apparent frequency of HSCs suggested by imaging and their rarity when
measured by limiting dilution transplant. We have attempted to reconcile this difference using
neonatal recipients, which are more permissive for embryonic HSC engraftment. We found that
embryonic HSCs from E9.5 and E10.5 preferentially engrafted neonates, whereas developmentally
mature, definitive HSCs from E14.5 fetal liver (FL) or adult bone marrow (BM) more robustly
engrafted adults. Neonatal engraftment was enhanced after treating adult BM-derived HSCs with
interferon. Adult BM-derived HSCs preferentially homed to the liver in neonatal mice yet showed
balanced homing to the liver and spleen in adults. These findings emphasize the functional
differences between nascent and mature definitive HSCs.
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Introduction
According to the classical definition, a definitive HSC reconstitutes multi-lineage
hematopoiesis long-term in irradiated adult primary transplant recipients, and can be serially
passed into secondary recipients, indicating the capacity for both self-renewal and multi-
lineage differentiation (Becker et al., 1963; Siminovitch et al., 1963; Till and Mc, 1961; Wu
et al., 1968). Under that definition, the first transplantable murine HSC emerges in vivo in
the AGM at E11.5 (de Bruijn et al., 2000; Kumaravelu et al., 2002; Medvinsky and
Dzierzak, 1996; Muller et al., 1994; Taylor et al., 2010). HSCs then migrate to the FL and
rapidly divide to build up the stem cell pool. Ultimately, HSCs populate the developing BM
where they become quiescent once homeostasis is reached in the post-natal period.
Interaction with specific niches during development allows embryonic HSCs to mature into
adult HSCs (Schofield, 1978; Wineman et al., 1996).
The surface antigen profile of the engrafting cell at E11.5, as identified by transplantation, is
VE-Cadherin + CD45+ CD34− cKitlow Sca1+ CD31low (Taoudi et al., 2008; Taoudi et al.,
2005). Imaging techniques coupled with the cell surface profile of the engrafting cell have
provided insight into the emergence of the definitive HSC (Boisset et al., 2010; Kissa and
Herbomel, 2010; Taoudi and Medvinsky, 2007; Yokomizo and Dzierzak, 2010). Imaging
has revealed hundreds of c-Kit+ clusters in E11.5 AGM, implying a discrepancy in the
quantity of potential HSCs identified by imaging relative to the frequency defined by
limiting dilution transplantation in adult recipients.
Analysis of emerging hematopoietic cells in the AGM at E10.5 shows 1.7 Sca1+ c-Kit+
CD31+ CD41+ cells per embryo (Boisset et al., 2010). Transplantation has revealed that
E10.5 AGM cells are capable of rare long-term multi-lineage repopulation of wild-type adult
recipients (3% of transplanted animals) and more robust repopulation in immunodeficient
adult recipients, indicating that the host environment plays a critical role in detection of
nascent HSCs (Bertrand et al., 2005; Muller et al., 1994; North et al., 2002). Interestingly,
VE-Cadherin+ CD45− cells from E10.5 AGM robustly reconstitute wild-type adult
recipients after 4 days of ex vivo culture, further suggesting that there are cells in the AGM
at E10.5 with enhanced potential to engraft if cultured under proper conditions (Rybtsov et
al., 2011).
Before E10.5, the tissues of the para-aortic splanchnopleura (PSp) contain progenitors that
are rimed to give rise to the definitive HSC, as per the classical definition (Cumano et al.,
2000; Cumano et al., 2001; Muller et al., 1994). A population from E9.5 PSp has been
reported to engraft immunodeficient adult recipients and wild-type neonatal recipients
(Kieusseian et al., 2012; Mizuochi et al., 2012; Yoder et al., 1997a). Neonatal engraftment
has also been observed from E9.0 yolk sac (Yoder et al., 1996; Yoder et al., 1997b),
suggesting that the neonate may be more permissive for engraftment of early embryonic
HSCs. Interestingly, we also found that definitive adult HSCs engraft less robustly in the
neonate relative to the adult. In this study we quantified nascent definitive HSCs in the
earliest intraembryonic tissues to date and identified the context in which HSCs from
different developmental stages will engraft.
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Results
Quantification of robust reconstitution of neonates with early embryonic tissues
We first compared engraftment of neonates and adults with cells from E11.5 AGM, the
earliest population reported to engraft wild-type adult recipients. Neonatal recipients were
more robustly engrafted than adult recipients with similar conditioning. Whereas 7/9
neonatal recipients were engrafted with 1ee, at most 3/6 adult recipients receiving sub-lethal
irradiation and no helper cells were engrafted at low levels (Figure 1 A and Table S1). Three
of 11 neonates transplanted with 0.25 embryo equivalents (ee) showed long-term
engraftment (Figure S1 A, B). Secondary transplants demonstrated donor HSC self-renewal
when taken from primary animals with multi-lineage reconstitution (Figure 1 B), but three
primary recipients with long-lived myeloid biased lineage skewing did not engraft secondary
recipients, and thus were not engrafted with a self-renewing HSC (Figure S1 B). We also
compared neonatal engraftment with E11.5 AGM to the current gold standard of lethally
irradiated adult recipients receiving helper cells. Only 1/8 adult mice was engrafted (Table
S1). Before quantitative analysis, these data suggest the neonatal transplant assay is a more
permissive functional test for early embryonic HSCs than the gold standard assay.
VE-Cadherin+ CD45+ cells from E11.5 AGM have been reported to engraft adult recipients
(Taoudi et al., 2005). Similarly, we found that the VE-Cadherin+ CD45+ but not the VE-
Cadherin + CD45− compartment engrafted neonates, thus demonstrating that neonates and
adults are engrafted with the same cells from E11.5 AGM (Figure S2 B). However, the
predicted repopulating cell frequency was higher in neonatal than adult recipients. Using the
neonatal transplant model, limiting dilution analysis (LDA) predicted 1 repopulating cell in
0.935 ee, thus quantifying the sensitivity of the neonatal system for engraftment of
embryonic HSCs (Table 1). In our hands using the adult transplant model with 300,000
helper cells, LDA predicted 1 repopulating cell in 5.7 ee of E11.5 AGM, whereas the
published frequency using adult recipients is approximately 1 per ee (Kumaravelu et al.,
2002) (Table 1). When we replicated the conditions from Kumaravelu et al. using 20,000
helper cells, the calculated frequency was 1 repopulating cell in 0.538 ee (Table 1). Thus,
our experimental quantifications reveal sensitivity in the adult transplant model to helper
dose and no preference of HSCs at E11.5 for neonatal recipients.
We then evaluated the engraftment potential of newly specified HSCs from earlier stages of
ontogeny. Neonates showed robust, long-term, multi-lineage reconstitution from 4 ee to 1 ee
of unfractionated E10.5 AGM (30–39 somites) (Figure 1 C and Figure S1 C). At 18 weeks
post-transplant, 3/5 recipients receiving 4 ee, 5/10 receiving 2 ee, and 5/10 receiving 1 ee
showed multi-lineage engraftment with an average of 28%, 22%, ad 11% donor
contribution, respectively. No neonates were engrafted with 0.5 ee. In comparison, no
engraftment was observed in adult recipients receiving up to 7 ee with as few as 20,000
helper cells (Table S1). Secondary transplants demonstrated self-renewal capacity of the
repopulating donor cells from E10.5 AGM (Figure 1 B). LDA predicted 1 repopulating cell
in 2.84 ee of E10.5 AGM when using the neonatal transplant model (Table 1), indicating
that the repopulating cell is less abundant in the AGM at E10.5 than it is at E11.5. These
data establish that whole E10.5 AGM robustly reconstitutes neonatal but not adult
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recipients, and demonstrate the existence of an HSC capable of long-term multi-lineage
reconstitution in the AGM of some embryos as early as E10.5.
When we examined reconstitution potential from even earlier in ontogeny, we detected long-
term multi-lineage donor chimerism from unfractionated E9.5 PSp (16–26 somites)
transplanted into neonates in doses from 8 ee to 1 ee (Figure 1 D and Figure S1 D). At 18
weeks post-transplant, 1/16 recipients receiving 8 ee, 2/5 receiving 5 ee, and 2/13 receiving
1 ee were engrafted at an average of 15%, 5%, and 2%, respectively. Curiously, mice
engrafted with E9.5 PSp showed an early B-cell skewing, which was not as pronounced in
neonates engrafted with E10.5 AGM and not seen with E11.5 AGM (Figure S1 D). LDA
predicted 1 repopulating cell in 44.8 ee of E9.5 PSp (Table 1). Secondary transplants
confirmed that the engrafting cell from E9.5 PSp was truly a self-renewing stem cell (Figure
1 B). These findings provide additional conclusive evidence for the existence of an
intraembryonic repopulating cell as early as E9.5 in some embryos.
Neonates are not more supportive for engraftment of adult-like HSCs
We next determined if the neonate is a more permissive recipient for all HSCs or only those
from the early embryo. LT-HSCs (Lineage− Sca1+ c-Kit+ CD150+ CD48−) from adult BM
(Kiel et al., 2005) were transplanted into neonatal and adult recipients in doses ranging from
100 cells to 10 cells (Figure 1 E and Table S1). Surprisingly, adult donor LT-HSCs failed to
give rise to robust engraftment in neonatal recipients monitored for up to 23 weeks. Adult
recipients were robustly engrafted, whereas engraftment in neonatal recipients was minimal.
At 18 weeks post-transplant, all adult recipients that received 100 cells and 3 of 5 animals
that received 10 cells showed multi-lineage engraftment. LDA from adult recipients
predicted 1 repopulating cell in 13.1 LT-HSCs from adult BM, which is less frequent than
published reports, which used 200,000 helper cells (Kiel et al., 2005). While considering
low-level engraftment of neonates, LDA predicted 1 repopulating cell in 177 LT-HSCs
(Table 1).
We mined published microarray data of HSCs from E11.5 AGM and adult BM to better
understand why HSCs from different developmental stages might prefer different transplant
hosts (McKinney-Freeman et al., 2012). Modules from the microarray data point to key
differences in cytokine-cytokine receptor interaction, transcription, metabolism, the toll-like
receptor signaling pathway, and membrane composition. With 324 differentially expressed
genes encoding membrane proteins, we hypothesized HSCs from various points in ontogeny
may home to unique niches in different hematopoietic tissues. Interestingly, all examined
genes known to be involved in homing (cxcr4, cd44, connexin-43, cd49d, lfa-1, and psgl1)
showed consistent expression between E11.5 AGM HSCs and adult BM HSCs.
To determine if a mature definitive HSC population from the FL could engraft neonates, we
transplanted cells with the same surface antigen profile (Lineage− Sca1+ c-Kit+ CD150+
CD48−) from E14.5 FL into neonatal and adult recipients in doses ranging from 100 cells to
10 cells (Figure 1 F and Table S1). Adult recipients had high level engraftment at all doses,
whereas neonatal engraftment was only robust with 100 donor cells. At 18 weeks post-
transplant, 10/16 neonatal recipients that received 100 cells showed balanced multi-lineage
reconstitution with an average of 22.7% donor contribution; whereas only 1/8 neonates
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transplanted with 50 cells, 2/6 transplanted with 25 cells, and 1/8 transplanted with 10 cells
were engrafted. LDA from neonatal recipients predicted 1 repopulating cell in 114 LT-
HSCs; whereas from adult recipients LDA predicted 1 repopulating cell in 25.7 LT-HSCs
(Table 1). Thus, while E14.5 FL LT-HSCs engrafted neonates more readily than adult BM
LT-HSCs, both classes of definitive LT-HSCs from FL and adult BM engrafted better in
irradiated adults than in neonates.
To further examine the differences between HSCs residing in the liver versus the BM, we
transplanted LT-HSCs from neonatal BM and neonatal liver into neonates. At 18 weeks
post-transplant, we observed a difference in the engraftment potential; more animals were
engrafted at higher levels with neonatal liver LT-HSCs (Figures 1 G and Table S1). These
data demonstrate a decrease in neonatal engraftment potential in HSCs residing in the BM,
whether neonatal or adult.
Improving neonatal engraftment potential of adult BM HSCs
We observed more robust engraftment in neonates transplanted with FL LT-HSCs compared
to BM LT-HSCs. FL LT-HSCs are rapidly cycling and expanding in the developing embryo,
while adult BM LT-HSCs are typically quiescent (Bowie et al., 2007b; Cheshier et al., 1999;
Harrison et al., 1997; Morrison et al., 1995). Thus we tested whether proliferation status
could influence the potential for definitive adult-like HSCs to engraft neonates. To drive
adult-like HSCs into the cell cycle, we treated adult mice with interferon-α (IFNα) and 5-FU
(Essers et al., 2009; Randall and Weissman, 1997; Sato et al., 2009; Venezia et al., 2004).
Cycling HSCs were then isolated and transplanted into neonatal recipients (Figure S3 A).
HSCs exposed to IFNα were able to engraft neonates and adults more robustly than PBS
treated controls (Figure 2 A). When HSCs were exposed to 5-FU, which has less effect on
quiescent HSCs than IFNα (Lerner and Harrison, 1990), we observed no enhancement of
neonatal engraftment (Figure S3 B). Further analysis of FL HSCs and BM HSCs treated
with IFNα and 5-FU through published microarrays revealed 43 up-regulated genes
common between FL HSCs and IFNα treated HSCs (Figure 2 B and C). The gene-ontogeny
categories of the commonly up-regulated genes are biological processes essential for
proliferation (Figure 2 D). Gene-set enrichment analysis showed 5-FU treated HSCs do not
up-regulate the same genes as IFNα treated HSCs or FL HSC (Figure S3 C), suggesting
IFNα and 5-FU have discrepant effects on HSCs, which may explain the difference in
neonatal engraftment potential. Adult BM HSCs exposed to G-CSF, another treatment
associated with HSC mobilization and activation of HSC cycling, likewise up-regulates the
commonly up-regulated genes in FL and IFNα treated HSCs (Figure S3 D). We also
observed that more neonatal liver LT-HSCs are proliferating than neonatal BM LT-HSCs,
suggesting that neonatal engraftment potential as well as proliferation decreases around birth
in HSCs that have migrated to the BM (Figure 2 E). Collectively, these data suggest that an
active cell cycle enhances neonatal engraftment but that additional elements are also at
work.
LT-HSCs home to different recipient tissues in neonates versus adults
We also hypothesized that HSCs from different developmental stages home to different
hematopoietic tissues in neonates and adults, which likely has a significant impact on long-
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term engraftability. We transplanted LT-HSCs from adult BM into neonatal or adult
recipients, and after 15 hours recovered and dissociated multiple tissues and surveyed for
donor cells by flow cytometry. We chose to examine the recipients 15 hours post-injection
to assess homing prior to proliferation of the donor cells (Driessen et al., 2003; Hendrikx et
al., 1996; Nilsson et al., 1997). At 15 hours post-transplant, we detected comparable
numbers of donor cells in both neonates and adults, indicating that a lack of short-term
donor cell survival could not account for the failure of adult LT-HSCs to engraft in
neonates. In adult recipients 42% of injected cells were detected in the liver, 48% in the
spleen, and 8.7% in the marrow of the leg bones. In neonatal recipients, 88% of injected
cells were detected in the liver, 4.3% in the spleen, and 6.9% in the marrow of the leg bones.
Very few or no donor cells were found in the thymus, peripheral blood, or lungs of either
adults or neonates (Figure 3). These data demonstrate that definitive adult-like HSCs home
to different tissues in neonates relative to adult recipients, which may underscore the
difference observed in long-term engraftment. We also assayed the homing of VE-
Cadherin+ CD45+ cells from E11.5 AGM but were unable to detect any donor cells at 15
hours post-transplant. This suggests few early embryonic HSCs survive 15 hours post-
transplants, and those that survive to contribute to reconstitution are too few to detect.
Discussion
Although prior literature suggests that the neonate harbors a more permissive environment
for engraftment of early HSCs (Yoder and Hiatt, 1997; Yoder et al., 1997b) and microarray
data of early and adult-like HSCs show differentially expressed genes with various
functional roles (McKinney-Freeman et al., 2012), there have been no prior reports directly
comparing and quantifying the repopulating cell frequency of HSCs from multiple points
during ontogeny in both neonatal and adult recipients. Here we highlight the importance of
the recipient in determination of engraftment outcomes, and identify several perplexing
differences between the capacity of nascent embryonic and definitive adult-like HSCs to
engraft either neonates or adults. Specifically, we show that nascent embryonic HSCs are
better suited to engraftment in neonates; conversely, definitive adult-like HSCs, whether
harvested from FL or adult BM, more efficiently reconstitute adult hosts. We used the
neonatal transplant model to better understand the engraftment requirements of adult HSCs
and identified two factors that may modulate neonatal engraftment potential, differential
proliferative activity and homing potential. The neonatal transplant assay provides a tool to
further our understanding of the factors required for survival, maturation, and function of
embryonic HSCs and can be utilized to functionally examine nascent HSC-like cells derived
from pluripotent stem cells.
Our data demonstrate robust long-term multi-lineage hematopoietic reconstitution of
unmanipulated, uncultured E10.5 AGM in wild-type murine recipients, thereby establishing
that definitive HSCs indeed arise within the embryo at this early stage, but a receptive host
is required to observe this functionality. Others have shown that E10.5 AGM and even E9.5
PSp can engraft immunodeficient adult recipients, suggesting that genetic
immunodeficiency in adult recipients enables the same permissiveness to engraftment of
embryonic cells as we observe in the neonate (Bertrand et al., 2005; Cumano et al., 2001;
Kieusseian et al., 2012; Levy, 2007; Marodi, 2006). Indeed, immaturity of the neonatal
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immune system may represent a reduced transplantation barrier for early embryonic HSCs,
which express lower levels of MHC Class I molecules, and are thus susceptible to rejection
by NK-mediated mechanisms (Cumano et al., 2001). Interestingly, we have also shown that
the neonate is not a more permissive recipient for HSCs from all stages of ontogeny, as
purified LT-HSCs from E14.5 FL and adult BM do not engraft neonates as robustly as
adults. Adult-like HSCs likely respond to the neonatal environment differently than early
HSCs because of the differential expression of genes involved in cytokine-cytokine receptor
interaction and membrane composition. The preference of immature HSCs for engraftment
in neonates may have clinical parallels in the tendency of umbilical cord blood to more
robustly engraft juveniles as compared to adults, a phenomenon which may not depend
entirely on cell dose (Gluckman, 2001; Laughlin et al., 2001; Wagner et al., 2002).
Our study suggests that HSC migration to the BM is coupled to limited neonatal engraftment
potential. HSCs harvested from the neonatal liver re-engraft in neonates more robustly than
HSCs harvested from the neonatal BM, indicating that either cell intrinsic changes that
trigger migration from the liver to the BM also cause decreased neonatal engraftment, or that
migration to the BM induces an alteration in HSCs that persists as the animal matures, as
adult BM HSCs yield no or low level engraftment in neonates. When we surveyed homing
of adult BM HSCs in neonatal and adult recipients, we found most donor cells in the liver in
neonates and the liver and spleen in adults.
Although we detected similar numbers of donor cells in neonates and adults, and a
comparable percent of donor cells homed to the BM in neonates and adults 15 hours post-
injection, long-term engraftment of adult BM HSCs in neonates was very poor. Several
potential explanations can be entertained to account for this. Coupled with our finding that
FL HSCs engraft neonates more robustly than adult BM HSCs, one possible explanation is
that the quiescent state of adult HSCs may not be suitable for engraftment in neonatal
recipients. Concentrations of steel factor in neonatal hematopoietic niches may play a role
(Bowie et al., 2007a). Recent work defines two distinct niches for cycling and quiescent
HSCs in adult BM, which may be present in different ratios or non-existent in the
developing neonatal BM (Kunisaki et al., 2013). Additionally, our neonatal engraftment
conditions permit only sublethal doses of irradiation, whereas engraftment of adults is
typically measured after lethal doses of irradiation. The sub-lethal irradiation of neonates
may not generate a sufficiently strong homeostatic drive to induce substantial proliferation
of the otherwise quiescent adult HSCs, especially considering the presence of competing
actively cycling neonatal HSCs.
In conclusion, we have used the neonatal transplant model to functionally assay the
engraftment potential of emerging early embryonic HSCs, which go undetected when using
wild-type adult recipients. Future studies using the neonatal transplant model may allow us
to discover new populations in hematopoietic tissues from other points in ontogeny that also
engraft neonatal but not adult recipients. Additionally, neonates may provide a unique
environment to functionally assay hematopoietic derivatives of pluripotent stem cells.
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Experimental Procedures
Bone Marrow Transplantation
Donor and recipient cells were distinguished by CD45.1 and CD45.2. Adult recipients were
either conditioned with a lethal dose of irradiation, 10 Gy total split by 3 hours, and received
3 × 105 cells from whole BM as helper or sublethally conditioned with a 3.5 Gy or 6.5 Gy
dose of irradiation and did not receive helper cells. Neonatal recipients, 1 – 2 days old, were
conditioned with a sublethal single dose of irradiation, 3.5 Gy, and received no helper cells.
HSC Proliferation
To induce HSC proliferation, adult mice were treated with one dose of IFNα (10,000 units
given subcutaneously) 24 hours prior to HSC isolation. Alternatively, adult mice received
one dose of 5-FU (150 mg kg−1) by intraperitoneal injection 5 days prior to HSC isolation.
Homing
Approximately 104 isolated cells were transplanted into neonatal and adult recipients.
Transplanting purified LT-HSCs in addition to injecting a small number of cells reduces the
likelihood of donor cells being trapped in the lung. At 15 hours post-injection, the lung,
peripheral blood, BM from the long bones of the leg, spleen, liver, and thymus were
analyzed by FACS.
Microarray Analysis
The microarray data were analyzed per standard protocol using R/Bioconductor. Data was
obtained from GEO accession: GSE14361 (Essers et al., 2009), GSE1559 (Venezia et al.,
2004), GSE37000 (McKinney-Freeman et al., 2012), and GSE55095 (Schuettpelz et al.,
2014).
For full details, see the supplemental experimental procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Quantification of robust reconstitution of neonates with early embryonic tissues
• Neonates are not more supportive for engraftment of adult-like HSCs
• Proliferation enhances neonatal engraftment potential of adult bone marrow
HSCs
• LT-HSCs home to different recipient tissues in neonates versus adults
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Figure 1. Neonates are only more permissive for engraftment of early embryonic HSCs
A) Adult (square) and neonatal (circle) recipients were both transplanted with 1ee of whole
E11.5 AGM. Also see Figure S2. B) Secondary transplants were carried out for primary
recipients engrafted with early embryonic HSCs. Neonatal recipients were transplanted with
limiting doses of C) whole E10.5 AGM and D) whole E9.5 PSp. Also see Figure S1. E)
Neonatal (circle) and adult (square) recipients were transplanted with 100 adult BM LT-
HSCs. *While in 3 neonatal recipients we detected a robust signal in the peripheral blood at
a single time point of 18 weeks in one experiment, substantially lower donor chimerism was
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observed in these mice at the next time point of 23 weeks, and no other experiments showed
this phenomenon, leading us to conclude that these data may have been a spurious
experimental artifact. F) Neonatal (circle) and adult (square) recipients were transplanted
with 100 E14.5 FL LT-HSCs. G) Neonatal recipients were transplanted with 50 neonatal
liver LT-HSCs (triangle) and 50 neonatal BM LT-HSCs (diamond). The numbers in the
graph legends reflect the number of animals engrafted over the number of animals
transplanted.
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Figure 2. Cycling adult LT-HSCs engraft neonates
A) Neonatal and adult recipients were transplanted with 100 BM LT-HSCs from adult mice
treated with IFNα (square) or PBS (circle). Data shown are at 18 weeks post-transplantation.
Using Fisher’s exact test to compare the percent of animals engrafted, the p-value is 0.5581,
whereas using student’s t-test to compare the average percent engraftment, the p-value is
0.1730. B) Depiction of overlap of up-regulated genes in IFNα-treated bone-marrow HSCs
(Essers et al. 2007) and FL HSCs (McKinney-Freeman et al., 2012) when compared to
untreated bone-marrow HSCs. Significance of overlap was determined via the
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hypergeometric test. C) List of commonly up-regulated genes. D) Top 10 gene-ontology
biological processes in commonly upregulated genes from panel B. E) Quantification of
FACS analysis of Ki-67+ LT-HSCs in neonatal liver and BM. Data shown is the mean ±
SEM of three experimental replicates with pooled samples. Paired t-test value = 0.065. Also
see Figure S3.
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Figure 3. Homing of adult LT-HSCs differs in adult and neonatal recipients
Percentages of GFP+ CD45.2+ donor adult BM LT-HSCs detected in six tissues in adult and
neonatal recipients 15 hours post-transplantation. Data shown is the mean ± SEM,
representing a total of 5 – 6 mice per condition with data collected in experimental duplicate
for adults and triplicate for neonates. Liver and spleen p-value < 0.05; lung, BM (BM),
thymus, and peripheral blood (PB) p-value > 0.05 as calculated by the student’s t-test.
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